Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Mesa Laboratories, Inc. (MLAB)

Compare
117.49
-1.17
(-0.99%)
At close: 4:00:01 PM EDT
117.49
0.00
(0.00%)
After hours: 4:05:08 PM EDT
Loading Chart for MLAB
  • Previous Close 118.66
  • Open 117.81
  • Bid 115.79 x 100
  • Ask 118.41 x 100
  • Day's Range 114.96 - 121.25
  • 52 Week Range 83.68 - 155.12
  • Volume 69,275
  • Avg. Volume 38,495
  • Market Cap (intraday) 638.395M
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) --
  • EPS (TTM) -46.32
  • Earnings Date May 29, 2025 - Jun 2, 2025
  • Forward Dividend & Yield 0.64 (0.54%)
  • Ex-Dividend Date Feb 28, 2025
  • 1y Target Est 150.00

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

www.mesalabs.com

736

Full Time Employees

March 31

Fiscal Year Ends

Recent News: MLAB

View More

Performance Overview: MLAB

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MLAB
10.80%
S&P 500 (^GSPC)
4.23%

1-Year Return

MLAB
5.45%
S&P 500 (^GSPC)
7.42%

3-Year Return

MLAB
53.63%
S&P 500 (^GSPC)
23.92%

5-Year Return

MLAB
42.69%
S&P 500 (^GSPC)
128.01%

Compare To: MLAB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MLAB

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    644.75M

  • Enterprise Value

    825.41M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.71

  • Price/Book (mrq)

    4.15

  • Enterprise Value/Revenue

    3.47

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -104.92%

  • Return on Assets (ttm)

    2.18%

  • Return on Equity (ttm)

    -89.38%

  • Revenue (ttm)

    237.75M

  • Net Income Avi to Common (ttm)

    -249.44M

  • Diluted EPS (ttm)

    -46.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    32.29M

  • Total Debt/Equity (mrq)

    136.34%

  • Levered Free Cash Flow (ttm)

    57.76M

Research Analysis: MLAB

View More

Company Insights: MLAB

Research Reports: MLAB

View More

People Also Watch